Two studies, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, show a person’s diet can significantly affect his or her chance of developing rheumatoid arthritis.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows rheumatoid arthritis patients who don’t respond to an anti-TNF experience better outcomes if they are prescribed a biologic therapy next instead of following the common practice of trying a second anti-TNF. The same researchers found (in a second study also presented at the ACR Annual Meeting) assessing the antidrug antibodies in these patients may help guide the selection of the next treatment option.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows certain fractures due to osteoporosis can cause premature death in people 45 and older. This is the largest study, to date, that shows a connection between these fractures and premature death.
Being overweight or obese can reduce the likelihood of achieving sustained remission of early rheumatoid arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
A new study, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, shows that treating rheumatoid arthritis patients toward a target of remission or low disease activity works immediately and leads to higher remission rates.
Cardiovascular disease deaths are declining in people who have been diagnosed with rheumatoid arthritis after the year 2000, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco. This decline is found when compared to people diagnosed with RA in previous decades as well as when compared to people without the disease – signifying an encouraging milestone.
A diagnosis of arthritis in a baby boomer doesn’t mean that person should exit the workforce. Two studies, presented this week at the American College of Rheumatology Annual Meeting in San Francisco, show this growing group often returns to work after retirement and takes little advantage of workplace accommodations for their disease.
Spacing exercise-based physical therapy sessions over a 12-month period while using three additional “booster” sessions periodically has been shown to be more cost effective than alternative physical therapy strategies in the treatment of knee osteoarthritis, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Resistance strength training reduces pain and increases function and treatment satisfaction in people with hand osteoarthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
A low-impact exercise program offered by Hospital for Special Surgery in senior centers is improving quality of life for many older adults with arthritis and other musculoskeletal conditions.
A new study by a group at Hospital for Special Surgery reveals that blacks in the U.S. are at a significantly higher risk of requiring a revision than American whites, and that socioeconomic factors may play an important role in revision risk.
Excessive weight loss aided by bariatric (weight loss) surgery has been linked to improved symptoms in people with psoriasis and psoriatic arthritis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Both Tai Chi and physical therapy positively impact pain, function and other symptoms of knee osteoarthritis – making Tai Chi a viable treatment alternative for people suffering with the degenerative disease, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Using a pedometer to measure the number of steps one takes in a day has been linked to lower fatigue in persons with rheumatoid arthritis, according to research presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
For the first time, chondroitin sulfate has been more successful than celecoxib in reducing the long-term progression of knee osteoarthritis (OA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in San Francisco.
Scientists at The University of Manchester have shown for the first time that the numbers of opiate receptors in the brain increases to combat severe pain in arthritis sufferers.
New research from Toronto Western Hospital’s Spodyloarthritis Program reveals people with a type of spinal arthritis called ankylosing spondylitis (AS) have a higher risk of dying from a heart attack or stroke than the general population.
Other topics include autism research, biofuel sources, nutrition supplements, and more...
Long-term use of naproxen (ALEVE), a type of nonsteroidal anti-inflammatory drug (NSAID), is often prescribed for chronic pain conditions such as osteoarthritis. However, because of NSAID-related gastrointestinal problems including stomach and intestinal inflammation and ulcers, many are unable to tolerate ongoing use. A new study, published in the American Journal of Physiology–Gastrointestinal and Liver Physiology, finds that a naproxen-derivative may provide both symptom relief and gastrointestinal protection. The research is highlighted as one of this month’s “best of the best” as part of the American Physiological Society’s APSselect program.
Trending news releases with the most views in a single day. Topics include: An anonymous donor for cancer research, solar storms and incidences of rheumatoid arthritis, vulnerabilities in genome’s ‘Dimmer Switches’, new treatments for Alzheimer's, How people make decisions for or against flu vaccinations.
New release reports correlation between incidences of rheumatoid arthritis and giant cell arteritis with solar cycles.
Trending news releases with the most views in a single day. Topics include: genetics, cancer, nanotech, elderly care, marketing research, energy, children's health, and immunology.
New UK research has challenged the assumption that people with rheumatoid arthritis always take their medication as prescribed.
Trending news releases with the most views in a single day. Topics include: gun regulation, psychology and altruism, big data, threats to coral reefs, extra-terrestrial life, personalized diets, metabolic syndrome and heart health, new drug target to treat arthritis, and archeologists find oldest tools.
Researchers at the La Jolla Institute for Allergy and Immunology, in collaboration with colleagues the University of California, San Diego, identified a novel drug target for the treatment of rheumatoid arthritis that focuses on the cells that are directly responsible for the cartilage damage in affected joints.
Arthritis Research UK-funded scientists at The University of Manchester have identified a new way in which genotyping can be used to predict disease outcomes among sufferers of rheumatoid arthritis.
A mixture of over-the-counter medicine and experimental drugs could be just what the doctor ordered to provide more effective pain relief for arthritis sufferers.
A study by researchers at Hospital for Special Surgery finds that patients who go home after knee replacement and receive physical therapy at home do as well as those who go to an in-patient rehabilitation facility.
A study at Hospital for Special Surgery finds that hip replacement surgery is an excellent option to alleviate pain and improve function in juvenile arthritis patients under age 35 when conservative treatments fail to provide relief.
Rice University catcher, John Clay Reeves, felt pain in his groin after a collision at the plate with an opposing player. He thought he had pulled a muscle, but it turns out he was suffering from a common condition seen in teens and young adults known as hip impingement.
A harmless fluorescent probe injected into a joint may make it easier to diagnose and monitor osteoarthritis, leading to better patient care. A new study led by biomedical researchers at Tufts University reports that such a probe successfully tracked the development of early to moderate osteoarthritis in male mice.
A mosquito-borne virus that has spread to the Caribbean and Central and South America and has caused isolated infections in Florida often causes joint pain and swelling similar to that seen in patients with rheumatoid arthritis.
Enzymes linked to diabetes and obesity appear to play key roles in arthritis and leukemia, potentially opening up new avenues for treating these diverse diseases, according to researchers at Washington University School of Medicine in St. Louis.
A study at Hospital for Special Surgery finds that older adults experienced less pain, reduced stiffness and less fatigue after participating in a hospital-based exercise program.
The Early RA Support and Education program at Hospital for Special Surgery addresses the needs of people with rheumatoid arthritis. After participating in the free program, based on patient-identified outcomes, 90 percent of participants said they could make informed decisions about their RA.
Hospital for Special Surgery researchers found that body mass index (BMI) plays a role in rheumatoid arthritis patients’ ability to achieve a sustained remission. Those who were significantly underweight or overweight/obese were the least likely to remain in remission.
More than 50 studies involving researchers from Hospital for Special Surgery in New York City will be presented at the American College of Rheumatology annual meeting in Boston.
A study by Hospital for Special Surgery researchers finds that total hip replacement is an excellent option for patients under age 35 when conservative treatments fail to provide relief.
A molecule in the blood shows promise as a marker to predict whether individual rheumatoid arthritis patients are likely to benefit from biologic medications or other drugs should be tried, a Mayo Clinic-led study shows. The protein, analyzed in blood tests, may help avoid trial and error with medications, sparing patients treatment delays and unnecessary side effects and expense. The research is among several Mayo Clinic studies presented at the American College of Rheumatology annual meeting in Boston.
Carefully employing a TNF inhibitor dose-reduction strategy can be just as effective at safely treating RA patients as regular dosing methods, while also saving approximately $7,500 per patient annually.
Physically demanding jobs may increase the effects of inflammation on the progression of ankylosing spondylitis, possibly leading to increased bone formation in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Mortality risk for patients with rheumatoid arthritis is reduced to that of the general population when patients are treated with the aim to meet a low disease activity score, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Secukinumab, an anti-IL-17A monoclonal antibody biologic drug, showed promise as a treatment for patients with active ankylosing spondylitis, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Rheumatologists at Geisinger Health System in Central Pennsylvania have developed a new model of rheumatoid arthritis patient care that is designed to improve quality while reducing costs, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Women with rheumatoid arthritis are at significantly higher risk of all-cause mortality, particularly respiratory causes, compared to women without the disease, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Baseline levels of serum interferon in rheumatoid arthritis patients may help rheumatologists determine who will have a poor response to tumor necrosis factor-alpha inhibitor drugs, and one day help rheumatologists determine the best treatment options for individual RA patients.
Not only does treatment with tumor necrosis factor (TNF) inhibitor biologic drugs not increase the risk of congestive heart failure in people with rheumatoid arthritis, but it may decrease the incidence of this serious cardiovascular disease in these patients, according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
Patients with rheumatic diseases who are treated with denosumab (Prolia®, Xgeva®) either alone, or in combination with either biologic or non-biologic disease-modifying antirheumatic drugs (DMARDs), do not appear to have a significant increased risk of infections.
Women using intrauterine devices (IUDs) may be at increased risk for producing autoantibodies related to the risk of developing rheumatoid arthritis (RA), according to new research findings presented this week at the American College of Rheumatology Annual Meeting in Boston.
People with rheumatoid arthritis who are currently taking biologic drugs may be safely vaccinated for the viral infection herpes zoster, according to new research findings presented this week at the American College of Rheumatology Annual Scientific Meeting in Boston.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right